Logo

Cofactor Genomics

In Brief This Week: Meridian Bioscience, BioMérieux, Applied DNA Sciences, More

News items for the week of Dec. 12, 2022.

Cofactor Genomics RNA-seq Assay Outperforms PD-L1 IHC to Predict Immunotherapy Responders
Premium

The firm is aiming to commercialize its OncoPrism assay in 2023 as a laboratory-developed test to identify head and neck cancer patients eligible for checkpoint inhibitors.

Cofactor Genomics Begins Multi-Site Clinical Trial for Immunotherapy Prediction Assay

The multi-center study is evaluating the use of Cofactor's OncoPrism test in predicting head and neck cancer patients' response to immunotherapy with other tumor types to follow.

Cofactor Genomics Cements Clinical Diagnostic Plans as Immunotherapy Prediction Data Builds
Premium

The firm highlighted a new study exploring immune-related gene expression in ovarian cancer and gave an update on its lead diagnostic candidate for head and neck tumors.

Cofactor Genomics, UCSD Partner on Metastatic Head, Neck Cancer Study

The company will work with university researchers to evaluate its predictive immune modeling technology in personalizing the use of immune checkpoint inhibitors.

Jan 4, 2019

Cofactor Genomics Hopes to Drive RNA Dx Progress With Kit Dissemination
Premium

Dec 4, 2018

Cofactor Genomics Inks Pilot Study Deal for Immune Profiling Kit Evaluation

Mar 20, 2018

Cofactor Genomics, NCI Partner to Validate RNA-Based Immune Profiling Assay

Feb 16, 2018

Cofactor Pushes RNA-Based Dx Goals With New Immuno-Oncology Assay
Premium

Sep 18, 2017

Cofactor Genomics Raises $18M in Series A Round

Mar 21, 2017

Cofactor Genomics Launches First RNA-Seq Clinical Assay
Premium

Dec 1, 2016

Cofactor Genomics, FLX Bio Partner on Immuno-Oncology Analysis Platform

Mar 1, 2016

Systems Imagination, Cofactor Genomics Ink Drug Development Services Deal

Feb 3, 2016

Cofactor Genomics Acquires Narus Biotechnologies

Jul 21, 2015

Cofactor Genomics Awarded $1.5M NIH Grant for Circular RNA Enrichment Tech

Feb 19, 2015

Cofactor Genomics Named Agilent CSP for NGS Target Enrichment

Sep 19, 2014

Cofactor Genomics Wins $300K Contract for Epigenetics Study of Cardiovascular Disease

Nov 19, 2013

Cofactor Genomics Doubles Sequencing Capacity and Launches RNA-seq Dx as it Moves into New Digs
Premium

Oct 8, 2013

Sage Labs Partners with Cofactor Genomics on RNA Sequencing Services

Mar 5, 2013

Cofactor Genomics Set to Offer Services in Exchange for Sequencer Trade-Ins
Premium

Mar 6, 2012

Paired Ends: Don Henricksen, Robert Nussbaum, Hesaam Esfandyarpour, Ron Davis, George Church, and More
Premium

Jan 13, 2012

Cofactor Taps Intrepid to Provide Visualization Capabilities for Cow Exome Capture Offering
Premium

Jan 10, 2012

Cofactor, Intrepid Integrate Cow Genome Analysis Tools

Dec 6, 2011

New Products: Cofactor Genomics' Bovine Exome Capture Kit; GIS's Opera; Bowtie Updated
Premium

Nov 1, 2011

Cofactor Genomics Collaborates with Kentucky Network on Sequencing Data

Breaking News
The Scan

Study Links Evolution of Longevity, Social Organization in Mammals

With the help of comparative phylogenetics and transcriptomics, researchers in Nature Communications see ties between lifespan and social organization in mammals.

Tumor Microenvironment Immune Score Provides Immunotherapy Response, Prognostic Insights

Using multiple in situ analyses and RNA sequence data, researchers in eBioMedicine have developed a score associated with immunotherapy response or survival.

CRISPR-Based Method for Finding Cancer-Associated Exosomal MicroRNAs in Blood

A team from China presents in ACS Sensors a liposome-mediated membrane fusion strategy for detecting miRNAs carried in exosomes in the blood with a CRISPR-mediated reporter system.

Drug Response Variants May Be Distinct in Somatic, Germline Samples

Based on variants from across 21 drug response genes, researchers in The Pharmacogenomics Journal suspect that tumor-only DNA sequences may miss drug response clues found in the germline.